Latest News for: cd226

Edit

Formation Bio Licenses First-in-Class Anti-CD226 Autoimmune Program from IMIDomics

Rio Grande Sun 30 Jul 2025
- Transaction expands Formation Bio's immunology pipeline with Phase 1 ready drug candidate ... .
  • 1
×